Open Government Portal
Found 10 records similar to Biosafety Directive for Human Immunodeficiency Virus (HIV) and Human T-cell Lymphotropic Virus Type 1 (HTLV-1)
Age-sex Specific Incidence Rates for HIV for Alberta expressed as per 100,000 population.
Geographical information about the locations of community-based HIV/AIDS organizations that deliver HIV prevention and support services to people living with or affected by HIV and to people at high risk of acquiring HIV.
In 2016, an estimated 63,110 people were living with HIV.
The number of persons who are infected with HIV and not yet tested (i.e. are not even aware themselves that they have HIV) is impossible to know precisely. This number is estimated using statistical models and methods with data from a variety of sources.
In 2018, 50% of Canadians had never been tested for HIV, hepatitis C, or STI.
HIV diagnosis rates remained stable over the last decade, with some minor fluctuations.
Find information, tools and facts about symptoms, risks and how to prevent, treat and manage HIV and AIDS.
What health professionals need to know about HIV and AIDS, prevention, disease progression, clinical manifestations, diagnosis, treatment and surveillance.
This guideline describes the general recommendations and considerations for basic laboratory design and the safe handling of RG1 biological material; these recommended practices are risk-and evidence-based. The physical design features and operational practices for CL1 zones described in this document are considered best practices for work involving RG1 pathogens.